Cargando...
Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis
Imetelstat (GRN163L) is a specific telomerase inhibitor that has demonstrated clinical activity in patients with myeloproliferative neoplasms (MPN) and in patients with solid tumors. The antitumor effects were associated with the development of thrombocytopenia, one of the common side effects observ...
Gardado en:
| Publicado en: | Leukemia |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5985670/ https://ncbi.nlm.nih.gov/pubmed/28270692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.78 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|